Get Tested For Hepatitis C! – Interview With Abbott’s Gavin Cloherty 28/05/2014 by Intellectual Property Watch Leave a Comment Gavin Cloherty is associate director of scientific affairs at the US molecular diagnosis developer Abbott Molecular. Abbott has a long-standing history of developing tests for detecting and monitoring hepatitis, among other areas. With Intellectual Property Watch, Cloherty discussed the burden of hepatitis C, the process of diagnosis and the importance of diagnosis for curbing and treating the disease.
WHO Takes Step Toward Policy Of Engagement With Lobbyists, Foundations 25/05/2014 by William New, Intellectual Property Watch Leave a Comment The World Health Organization today (24 May) adopted a one-year plan to come up with a policy on engagement with “non-state actors” – industry, nongovernmental groups, foundations and academics.
WHA: New Draft Decision On Non-State Actors Sets Plan For Next Year 23/05/2014 by William New, Intellectual Property Watch 1 Comment A new draft decision putting action on a proposal for external actors’ engagement with the World Health Organization on track for next year will be considered by a committee at the World Health Assembly.
WHA: Experts Discuss Innovation, Access For Middle Income Countries 23/05/2014 by Joséphine De Ruyck for Intellectual Property Watch and Julia Fraser for Intellectual Property Watch Leave a Comment Country officials, academics and leading global health advocates this week raised one of the key concerns of this year’s World Health Assembly: innovation and access to medicines in middle-income countries. Government procurement strategies, voluntary and compulsory licensing, de-linkage models and UNITAID mechanisms were among some of the solutions put forward.
No Agreement On Management Of WHO Relationship With External Actors 22/05/2014 by Catherine Saez, Intellectual Property Watch 2 Comments After several drafting sessions this week meant to finalise a framework to govern the engagement of the World Health Organization with the private sector, nongovernmental organisations, foundations and academics, country delegates admitted defeat today at the World Health Assembly.
World Health Assembly: Panels Discuss Diagnostics, Surveillance, R&D Models For Antibiotic Resistance 22/05/2014 by Julia Fraser for Intellectual Property Watch Leave a Comment Multiple stakeholders are pushing for a World Health Organization-led global action plan to curb antimicrobial resistance.
Role Of Industry, NGOs, Foundations At WHO Under Intense Debate 21/05/2014 by Catherine Saez, Intellectual Property Watch 1 Comment A proposal to increase the engagement of “non-state actors” – industry, nongovernmental organisations, foundations and academics – in the activities of the World Health Organization is under intense debate at the annual World Health Assembly this week.
Sanofi-WHO Partnership Could Eliminate Sleeping Sickness By 2020 21/05/2014 by William New, Intellectual Property Watch Leave a Comment A side event to this week’s World Health Assembly highlighted progress being made in a public-private partnership on the elimination of sleeping sickness, a disease that occurs in some developing countries.
IP-Watch Subscribers – Updated List Of IP Delegates In Geneva 13/05/2014 by Julia Fraser for Intellectual Property Watch and Maëli Astruc for Intellectual Property Watch Leave a Comment The Geneva IP delegates list is updated! As a special feature for our subscribers, Intellectual Property Watch has assembled a new list of many of the leading government delegates working on intellectual property issues in Geneva.
Special Report – Students To Universities: “We Have A Drug Problem” 13/05/2014 by Julia Fraser for Intellectual Property Watch 6 Comments BASEL — Students from around the world are gathering momentum to challenge their universities’ licensing policies and research and development systems. That was one of the messages emerging from the annual meeting of Universities Allied for Essential Medicines (UAEM) Europe.